{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:46:36Z","timestamp":1707525996219},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,8]]},"DOI":"10.7759\/cureus.53833","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T13:09:59Z","timestamp":1707397799000},"source":"Crossref","is-referenced-by-count":0,"title":["Neonatal Renal Failure Following Intrauterine Exposure to an Angiotensin-Converting Enzyme Inhibitor"],"prefix":"10.7759","author":[{"given":"In\u00eas","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Quintela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Jardim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Pissarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.05.045","article-title":"Renin angiotensin system blocker fetopathy: a Midwest pediatric nephrology consortium report","volume":"167","author":"Nadeem S","year":"2015","unstructured":"Nadeem S, Hashmat S, Defreitas MJ, et al.. Renin angiotensin system blocker fetopathy: a Midwest pediatric nephrology consortium report. J Pediatr. 2015, 167:881-5. 10.1016\/j.jpeds.2015.05.045","journal-title":"J Pediatr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.196352","article-title":"Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review","volume":"60","author":"Bullo M","year":"2012","unstructured":"Bullo M, Tschumi S, Bucher BS, Bianchetti MG, Simonetti GD. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review. Hypertension. 2012, 60:444-50. 10.1161\/HYPERTENSIONAHA.112.196352","journal-title":"Hypertension"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2005.11.001","article-title":"Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists","volume":"82","author":"Quan A","year":"2006","unstructured":"Quan A. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev. 2006, 82:23-8. 10.1016\/j.earlhumdev.2005.11.001","journal-title":"Early Hum Dev"},{"key":"ref4","article-title":"Fetal abnormality associated with the use of captopril during pregnancy","volume":"60","author":"Duminy PC","year":"1981","unstructured":"Duminy PC, Burger PD. Fetal abnormality associated with the use of captopril during pregnancy. S Afr Med J. 1981, 60:805.","journal-title":"S Afr Med J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/2050312119843700","article-title":"Hypertension in pregnancy: pathophysiology and treatment","volume":"7","author":"Braunthal S","year":"2019","unstructured":"Braunthal S, Brateanu A. Hypertension in pregnancy: pathophysiology and treatment. SAGE Open Med. 2019, 7:2050312119843700. 10.1177\/2050312119843700","journal-title":"SAGE Open Med"},{"key":"ref6","unstructured":"NICE. Hypertension in adults. diagnosis and management. (2019). Accessed: December 15, 2023: https:\/\/www.nice.org.uk\/guidance\/ng136."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002233","article-title":"Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: an observational study","volume":"38","author":"Weber-Schoendorfer C","year":"2020","unstructured":"Weber-Schoendorfer C, Kayser A, Tissen-Diabat\u00e9 T, et al.. Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: an observational study. J Hypertens. 2020, 38:133-41. 10.1097\/HJH.0000000000002233","journal-title":"J Hypertens"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/226589-neonatal-renal-failure-following-intrauterine-exposure-to-an-angiotensin-converting-enzyme-inhibitor","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:18:41Z","timestamp":1707506321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/226589-neonatal-renal-failure-following-intrauterine-exposure-to-an-angiotensin-converting-enzyme-inhibitor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.53833","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,8]]}}}